Tuberous Sclerosis

Faculty

Needs Statement

Tuberous Sclerosis (TSC) is a disorder affecting 1:6000 individuals of all races, age, and gender. The disease carries significant morbidity involving multiple organ systems in pediatric patients. Because of the complexity and extent of disease involvement, primary care providers and subspecialists for pediatric patients alike need to be familiar with the primary disease manifestations and their management so as to provide the best possible outcomes and optimal quality of life in patients with TSC.

Target Audience

Primary care providers and subspecialists for pediatric patients.

Objectives

Upon completion of this activity, participants should be able to:

1. Identify major and minor clinical diagnostic features of TSC;

2. Implement standard clinical practices for the diagnosis, screening, and treatment of those TSC features with highest disease-associated morbidity and mortalit;

3. Discuss the emerging treatment role for pharmacologic inhibitors of the mammalian target of rapamycin (mTOR) in patients with TSC.

Accreditation

CME
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

Faculty Disclosure

Darcy A. Krueger, MD, PhD, (speaker and planner) has relevant financial relationships with commercial interests as follows:
Novartis - Principal Co-investigator - Research Grant
Dr. Krueger does not intend to discuss the off-label use of a product.

No staff members have any relevant financial relationships to disclose.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.